Guangzhou Panyu Central Hospital
26
2
3
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
3.8%
1 terminated/withdrawn out of 26 trials
85.7%
-0.8% vs industry average
27%
7 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (26)
Study of Toripalimab for Limited-Stage Small Cell Lung Cancer Following Concurrent Chemoradiotherapy
Role: collaborator
Guiding Fluid Resuscitation in Septic Shock: Ultrasound vs. Noninvasive Cardiac Output Monitoring
Role: collaborator
Application of PDCA Cycle in Tracheal Intubation Training for Emergency Medicine Residents
Role: lead
Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma
Role: collaborator
CLAG+VEN vs CLAG in the Treatment of Relapsed/Refractory AML
Role: collaborator
Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma
Role: collaborator
Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes
Role: collaborator
Efficacy of Transcutaneous Vagus Nerve Stimulation Paired With Tailor-Made Notched Music Therapy Versus Tailor-made Notched Music Training for Chronic Subjective Tinnitus
Role: collaborator
Dynamic Follow-up of Symptoms Based on Patient-reported Outcomes in Immunotherapy for Esophageal Cancer: a Prospective Multicentre Cohort Study (SPRING)
Role: collaborator
Combination of Sorafenib With Standard Therapy in Newly Diagnosed Adult CBF AML
Role: collaborator
reGional Network for Acute Myocardial Infarction
Role: collaborator
The Red Blood Cells Based Blood Test for Lung Cancer EARLY Detection
Role: collaborator
BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT
Role: collaborator
Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients
Role: collaborator
Single-agent Capecitabine as Metronomic Chemotherapy in LAHNSCC (CMHN)
Role: collaborator
Vonoprazan Fumarate in Combination With Amoxicillin for the First-line Eradication of Helicobacter Pylori -- a Multicenter, Randomized, Parallel Controlled Study
Role: collaborator
Web basEd soCial Media tecHnology to Improvement in Adherence to Dual anTiplatelet Therapy Following Drug-Eluting Stent Implantation
Role: collaborator
The Study Design of a Mobile Health (mHealth) Technology Associated Improvement of Drug Adherence in Patients With Acute Myocardial Infarction and Protocol for the Randomized, Controlled Trial(RESCIND-3)
Role: collaborator
Long-term MOno-Antiplatelet Drug Strategy After PerCutanEous CoronAry InterveNtion
Role: collaborator
Multi-Center Study of Different Doses Domperidone in Feeding Intolerance
Role: collaborator